Bibika, M.; Kanellopoulos, P.; Rouchota, M.; Loudos, G.; Nock, B.A.; Krenning, E.P.; Maina, T.
Diagnosis of Prostate Cancer with a Neurotensin–Bombesin Radioligand Combination—First Preclinical Results. Pharmaceutics 2024, 16, 1223.
https://doi.org/10.3390/pharmaceutics16091223
AMA Style
Bibika M, Kanellopoulos P, Rouchota M, Loudos G, Nock BA, Krenning EP, Maina T.
Diagnosis of Prostate Cancer with a Neurotensin–Bombesin Radioligand Combination—First Preclinical Results. Pharmaceutics. 2024; 16(9):1223.
https://doi.org/10.3390/pharmaceutics16091223
Chicago/Turabian Style
Bibika, Maria, Panagiotis Kanellopoulos, Maritina Rouchota, George Loudos, Berthold A. Nock, Eric P. Krenning, and Theodosia Maina.
2024. "Diagnosis of Prostate Cancer with a Neurotensin–Bombesin Radioligand Combination—First Preclinical Results" Pharmaceutics 16, no. 9: 1223.
https://doi.org/10.3390/pharmaceutics16091223
APA Style
Bibika, M., Kanellopoulos, P., Rouchota, M., Loudos, G., Nock, B. A., Krenning, E. P., & Maina, T.
(2024). Diagnosis of Prostate Cancer with a Neurotensin–Bombesin Radioligand Combination—First Preclinical Results. Pharmaceutics, 16(9), 1223.
https://doi.org/10.3390/pharmaceutics16091223